rubiarbonone C

selective inhibitor of cytochrome P450 4F enzymes

Also Known As:

((1R,3S,3aR,5aS,5bS,6S,7aR,11aS,13aR,13bR)-1,6-Dihydroxy-3-isopropyl-5a,8,8,11a,13a-pentamethyl-9-oxo-1,2,3,4,5,5a,5b,6,7,7a,8,9,10,11,11a,13,13a,13b-octadecahydro-3aH-cyclopenta(a)chrysen-3a-yl)methy l acetate; 9H-Cyclopenta(a)chrysen-9-one, 3a-((acetyloxy)methyl)-1,2,3,3a,4,5,5a,5b,6,7,7a,8,10,11,11a,13,13a,13b-octadecahydro-1,6-dihydroxy-5a,8,8,11a,13a-pentamethyl-3-(1-methylethyl)-, (1R,3S,3aR,5aS,5bS,6S, 7aR,11aS,13aR,13bR)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - rubiarbonone C: 1

Experts

1.	Han, Joo-Hui: 1 article (11/2017)
2.	Heo, Kyung-Sun: 1 article (11/2017)
3.	Jo, Eunji: 1 article (11/2017)
4.	Jung, Sang-Hyuk: 1 article (11/2017)
5.	Lee, Do-Hyung: 1 article (11/2017)
6.	Lim, Tae-Wan: 1 article (11/2017)
7.	Myung, Chang-Seon: 1 article (11/2017)
8.	Na, MinKyun: 1 article (11/2017)
9.	Park, Hyun-Soo: 1 article (11/2017)
10.	Quan, Khong Trong: 1 article (11/2017)

Related Diseases

1.	Cardiovascular Diseases (Cardiovascular Disease) 11/01/2017 - "Therefore, rubiarbonone C could be a good candidate for the treatment of cardiovascular disease."